Cormorant Pharmaceuticals' Acquisition

Cormorant Pharmaceuticals was acquired by Bristol-Myers Squibb on July 05, 2016.

Cormorant Pharmaceuticals is a biopharmaceutical company focusing on the development of therapies for cancer and rare diseases.…

Articles about Cormorant Pharmaceuticals' Acquisition: